Evidence map›Paper›PMID 41808188›Full record

SynthesisTrials2026

Views on consent approaches used in emergency and critical care research: a rapid, systematic review.

Niamh Mahon, Leanne M C Hays, Eva Coy, Kate Ainscough, Aidan Burrell, Anthony C Gordon, Bram Rochwerg, Chun-Mei Wang, Dan Harvey, Dhruv Parekh and 10 more

Abstract readSystematic Review
In one paragraph

Synthesis in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Niamh MahonUniversity College Dublin Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland.
Leanne M C HaysUniversity College Dublin Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland.
Eva CoyUniversity College Dublin Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland.
Kate AinscoughUniversity College Dublin Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland.
Aidan BurrellDepartment of Intensive Care, The Alfred Hospital, Melbourne, Australia.
Anthony C GordonDivision of Anaesthetics, Pain Medicine, and Intensive Care, Imperial College London, London, England, UK.
Bram RochwergDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Chun-Mei WangDepartment of Critical Care Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Dan HarveyNottingham University Hospital NHS Trust, Derby Road, Nottingham, NG72UH, UK.
Dhruv ParekhUniversity of Birmingham, Birmingham, UK.
Ewan GoligherInterdepartmental Division of Critical Care Medicine and Department of Physiology, University of Toronto, Toronto, ON, Canada.
Fiona ToalNational Neurosciences Centre, Beaumont Hospital, Dublin, Ireland.
Hiroki SaitoSt. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
John C MarshallInterdepartmental Division of Critical Care Medicine and Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Jonathan StewartQueen's University Belfast, Belfast, UK.
Nina GobatNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England, UK.
Steve WebbAustralian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Timo TolppaDepartment of Experimental Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
Danny F McAuleyQueen's University Belfast, Belfast, UK.
Alistair D NicholUniversity College Dublin Clinical Research Centre, St. Vincent's University Hospital, Dublin, Ireland. alistair.nichol@ucd.ie.

Funding

Efficacy and Mechanism Evaluation Programme NIHR154493Health Research Board APRO-2023-017Health Research Board CTN-2021-010Health Research Board DIFA-2023-025Health Technology Assessment Programme NIHR155209
6 · The paper itself

Abstract

backgroundObtaining informed consent can be challenging in emergency and critical care research due to the acute and severe nature of the patient's condition. However, such research is urgently needed to inform practice and optimise patient outcomes. While alternative consent approaches have been commonly used, opinions may vary, particularly among diverse and underserved patient groups and in the context of the recent COVID-19 pandemic. The objective of this review was to assess views of alternative consent methods in emergency and critical care research.

methodsWe conducted a rapid systematic review to understand diverse opinions of alternative consent models used in emergency and critical care research with searches of MEDLINE, EMBASE, PsycINFO, Web of Science and CENTRAL carried out to July 31, 2024. We included quantitative and qualitative studies and summarised findings using narrative synthesis. We specifically investigated underserved groups and consent in the pandemic setting.

resultsFrom 9974 citations, we screened 289 full-text articles, and included 145 eligible studies from 26 countries. Consent methods included prospective informed consent, deferred consent, surrogate decision maker consent, healthcare professional consent and waived consent. Groups represented included previous trial participants, relatives of trial participants, patients, members of the general public, healthcare providers, researchers, site staff, and research ethics committees. It was recognised that prospective informed consent from the patient is not possible in all scenarios. In general, alternative consent models were acceptable, with emphasis on the inclusion of the patient and relatives in the decision-making process whenever possible. Acceptability of alternative consent models was influenced by previous research participation, experience of critical or emergency illness, perceived risk of participation, and invasiveness of the intervention. Study staff highlighted potential limitations of some alternative consent models, such as unavailability of relatives. Pandemic studies showed an increased need for alternative consent methods, and greater preparedness and engagement with ethics committees to facilitate implementation. Sub-analysis evaluating the views of underserved groups did not show consensus, and accommodations were largely not reported.

conclusionAlternative consent models used for emergency, critical care and pandemic research including deferred consent, relative/surrogate decision maker consent, and physician consent were generally acceptable.

trial registrationPROSPERO CRD42023408305 (April 19, 2023).

Indexed as

COVID-19Critical CareInformed ConsentHumansSARS-CoV-2Third-Party ConsentConsentCritical care researchDiversityEmergency researchInclusionIntensive carePandemic researchRapid reviewSurrogate decision maker

Identifiers

PMID41808188
PMCPMC13088460

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.